Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axogen Inc
(NQ:
AXGN
)
9.240
-0.090 (-0.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axogen Inc
< Previous
1
2
3
Next >
Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023
October 18, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™
September 05, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
August 31, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
A Preview Of Axogen's Earnings
March 13, 2023
Via
Benzinga
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
August 21, 2023
From
Axogen, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 08, 2023
Via
Benzinga
Dow Drops 343 Points Amid Bank Sector Gloom
August 08, 2023
Stocks are extending their morning losses, with the banking sector weighing on the market after Moody cut its credit rating on several U.S. banks.
Via
Talk Markets
Axogen, Inc. Reports 2023 Second Quarter Financial Results
August 07, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 08, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...
Via
Benzinga
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference
July 27, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023
July 26, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at Jefferies Healthcare Conference
May 24, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at JMP Securities Life Sciences Conference
May 12, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports 2023 First Quarter Financial Results
May 09, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
April 18, 2023
From
Axogen, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 14, 2023
Via
Benzinga
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
March 14, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
March 06, 2023
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
March 02, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
February 13, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
January 09, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
January 05, 2023
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including...
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
December 19, 2022
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc Reports 2022 Third Quarter Financial Results
November 08, 2022
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
November 03, 2022
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.
October 31, 2022
Dr. Tyndall is currently the Executive Vice President for Health Affairs and Dean of Morehouse School of Medicine.
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022
October 20, 2022
From
Axogen, Inc.
Via
GlobeNewswire
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
September 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.